Drug Type Small molecule drug  | 
Synonyms  | 
Target  | 
Action stimulants, agonists  | 
Mechanism TREK1 stimulators(potassium two pore domain channel subfamily K member 2 stimulants), TREK2 agonists(potassium two pore domain channel subfamily K member 10 agonists)  | 
Therapeutic Areas  | 
Active Indication-  | 
Inactive Indication  | 
Originator Organization  | 
Active Organization-  | 
Inactive Organization  | 
License Organization-  | 
Drug Highest PhasePendingPreclinical  | 
First Approval Date-  | 
Regulation-  | 
Molecular FormulaC21H20N2O3S  | 
InChIKeyOUAZWUKQRHZQNC-CABCVRRESA-N  | 
CAS Registry2415154-29-7  | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Neurogenic Inflammation | Preclinical | China   | 09 Apr 2020 | |
| Pain | Preclinical | China   | 09 Apr 2020 | 





